BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Vancouver - ECPv6.17.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Vancouver
X-ORIGINAL-URL:https://scienceinvancouver.com
X-WR-CALDESC:Events for Science in Vancouver
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20230223T000000
DTEND;TZID=America/Vancouver:20230223T120000
DTSTAMP:20230210T224249Z
CREATED:20230210T224249Z
LAST-MODIFIED:20230210T224249Z
UID:28254-1677110400-1677153600@scienceinvancouver.com
SUMMARY:Access to Innovation
DESCRIPTION:Our 8th Annual Access to Innovation conference is a full day event that brings together life sciences leaders from academia\, research\, health institutions\, government\, and industry to discuss emerging trends\, innovation\, economic impact\, translational science\, and policies to advance the sector. This year’s event will resume in person. \nThe BC life sciences sector has never been stronger\, leading the country in the pace of discovery and company creation. By leveraging our world-class research\, we are well-positioned to deliver innovative product solutions and services critical to the health system while driving economic diversification and competitiveness. \nAs leaders\, we need to seize the opportunity to significantly advance the sector and ensure that BC builds on the extraordinary momentum of the last few years by working together to develop policies and strategies that attract capital and talent and enable scale. The time for sustained collaborative action – between industry\, research and academia\, and government – is now. \nPlease join us as we dive into the most pressing issues facing the BC life sciences sector. \nConfirmed Speakers: \nPaul Armitage\, Partner\, Gowling WLG\nDr. Julia Bickford\, Regional Director\, Research Evaluation and Analytics\, Northern Health\nDr. Michael Chen\, Clinical Pathologist\, Department of Laboratory Medicine\, Island Health; Adjunct Assistant Professor\, University of British Columbia & University of Victoria\nAbi Coman-Walker\, COO\, Acuitas Therapeutics\nStephen Filby\, Founder & Principal Consultant\, WestPAR Consultancy\nDr. David Goodlett\, Professor\, University of Victoria; Director\, University of Victoria-Genome BC Proteomics Centre\nDr. Fraser Hof\, AVP Research\, University of Victoria\nDr. Diana Ionescu\, Clinical Professor\, University of British Columbia; Consultant Pathologist\, BC Cancer Agency\nDr. Tim Jacobs\, Director\, Molecular Design & Engineering\, AbCellera\nDr. Shirin Kalyan\, VP\, Scientific Innovation\, Qu Biologics\nDr. Barb Kinnaird\, CEO\, Response Biomedical\nDr. Véronique Lecault\, COO\, AbCellera\nJennifer Marles\, Partner\, Oyen Wiggs\nDr. Robert McMaster\, Vice Dean\, Research & Professor\, Department of Medical Genetics\, University of British Columbia\nNathan Michaels\, Director\, Precision Medicine and Genetic Services\, Ministry of Health\nAlison Orth\, Director\, Clinical Trials BC\, Michael Smith Health Research BC\nDr. Federica Di Palma\, CSO & VP\, Research and Innovation\, Genome BC\nEric Petersson\, Trade Commissioner\, Pacific Regional Office\, Global Affairs Canada\nDarcia Pope\, Chief Transformation Officer & Vice President\, Innovation & Planetary Health\, Vancouver Coastal Health\nAndrea Sambati\, President and CEO\, Boehringer Ingelheim Canada\nAngie Schick\, Executive Director\, New Ventures BC\nHelen Sheridan\, Chief Human Resources Officer\, STEMCELL Technologies\nDr. Cynthia Shippam\, Industry Technology Advisor\, National Research Council Canada – IRAP\nDr. Ted Steiner\, Professor\, Medicine & Head of the Division of Infectious Diseases\, University of British Columbia\nDr. Gavin C.E. Stuart\, Professor\, Department Obstetrics and Gynecology\, University of British Columbia\nJames Taylor\, General Manager\, Genomics Medicine\, Cytiva\nDr. Ali Tehrani\, Venture Partner\, Amplitude Ventures\nDr. Bryan Tennant\, Scientific Director\, Medical Affairs – Vaccines\, GSK\nCarlene Todd\, VP Access\, Roche\nLaura Walsh\, Senior Vice President\, Philanthropy\, VGH & UBC Hospital Foundation\nDr. Stephen Yip\, Neuropathologist\, Vancouver General Hospital; Medical Director of CGL/CCG\, BC Cancer\nConfirmed Session Themes: \nA Vision for Clinical Trials in British Columbia\nEvolving Access to Innovations in Precision Medicine\nImmuno-engineering: From Genomics to Therapeutics\nInnovations in Infection and Immunity\nLicensing and Collaboration Agreements in the Life Sciences Sector\nNavigating Government Support of IP Strategies
URL:https://scienceinvancouver.com/event/access-to-innovation-2-2/
LOCATION:Vancouver Convention Centre West\, 1055 Canada Pl\, Vancouver
ATTACH;FMTTYPE=:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20230223T000000
DTEND;TZID=America/Vancouver:20230223T120000
DTSTAMP:20230210T224249Z
CREATED:20230210T224249Z
LAST-MODIFIED:20230210T224249Z
UID:31338-1677110400-1677153600@scienceinvancouver.com
SUMMARY:Access to Innovation
DESCRIPTION:Our 8th Annual Access to Innovation conference is a full day event that brings together life sciences leaders from academia\, research\, health institutions\, government\, and industry to discuss emerging trends\, innovation\, economic impact\, translational science\, and policies to advance the sector. This year’s event will resume in person. \nThe BC life sciences sector has never been stronger\, leading the country in the pace of discovery and company creation. By leveraging our world-class research\, we are well-positioned to deliver innovative product solutions and services critical to the health system while driving economic diversification and competitiveness. \nAs leaders\, we need to seize the opportunity to significantly advance the sector and ensure that BC builds on the extraordinary momentum of the last few years by working together to develop policies and strategies that attract capital and talent and enable scale. The time for sustained collaborative action – between industry\, research and academia\, and government – is now. \nPlease join us as we dive into the most pressing issues facing the BC life sciences sector. \nConfirmed Speakers: \nPaul Armitage\, Partner\, Gowling WLG\nDr. Julia Bickford\, Regional Director\, Research Evaluation and Analytics\, Northern Health\nDr. Michael Chen\, Clinical Pathologist\, Department of Laboratory Medicine\, Island Health; Adjunct Assistant Professor\, University of British Columbia & University of Victoria\nAbi Coman-Walker\, COO\, Acuitas Therapeutics\nStephen Filby\, Founder & Principal Consultant\, WestPAR Consultancy\nDr. David Goodlett\, Professor\, University of Victoria; Director\, University of Victoria-Genome BC Proteomics Centre\nDr. Fraser Hof\, AVP Research\, University of Victoria\nDr. Diana Ionescu\, Clinical Professor\, University of British Columbia; Consultant Pathologist\, BC Cancer Agency\nDr. Tim Jacobs\, Director\, Molecular Design & Engineering\, AbCellera\nDr. Shirin Kalyan\, VP\, Scientific Innovation\, Qu Biologics\nDr. Barb Kinnaird\, CEO\, Response Biomedical\nDr. Véronique Lecault\, COO\, AbCellera\nJennifer Marles\, Partner\, Oyen Wiggs\nDr. Robert McMaster\, Vice Dean\, Research & Professor\, Department of Medical Genetics\, University of British Columbia\nNathan Michaels\, Director\, Precision Medicine and Genetic Services\, Ministry of Health\nAlison Orth\, Director\, Clinical Trials BC\, Michael Smith Health Research BC\nDr. Federica Di Palma\, CSO & VP\, Research and Innovation\, Genome BC\nEric Petersson\, Trade Commissioner\, Pacific Regional Office\, Global Affairs Canada\nDarcia Pope\, Chief Transformation Officer & Vice President\, Innovation & Planetary Health\, Vancouver Coastal Health\nAndrea Sambati\, President and CEO\, Boehringer Ingelheim Canada\nAngie Schick\, Executive Director\, New Ventures BC\nHelen Sheridan\, Chief Human Resources Officer\, STEMCELL Technologies\nDr. Cynthia Shippam\, Industry Technology Advisor\, National Research Council Canada – IRAP\nDr. Ted Steiner\, Professor\, Medicine & Head of the Division of Infectious Diseases\, University of British Columbia\nDr. Gavin C.E. Stuart\, Professor\, Department Obstetrics and Gynecology\, University of British Columbia\nJames Taylor\, General Manager\, Genomics Medicine\, Cytiva\nDr. Ali Tehrani\, Venture Partner\, Amplitude Ventures\nDr. Bryan Tennant\, Scientific Director\, Medical Affairs – Vaccines\, GSK\nCarlene Todd\, VP Access\, Roche\nLaura Walsh\, Senior Vice President\, Philanthropy\, VGH & UBC Hospital Foundation\nDr. Stephen Yip\, Neuropathologist\, Vancouver General Hospital; Medical Director of CGL/CCG\, BC Cancer\nConfirmed Session Themes: \nA Vision for Clinical Trials in British Columbia\nEvolving Access to Innovations in Precision Medicine\nImmuno-engineering: From Genomics to Therapeutics\nInnovations in Infection and Immunity\nLicensing and Collaboration Agreements in the Life Sciences Sector\nNavigating Government Support of IP Strategies
URL:https://scienceinvancouver.com/event/access-to-innovation-2-3/
LOCATION:Vancouver Convention Centre West\, 1055 Canada Pl\, Vancouver
ATTACH;FMTTYPE=:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20230223T000000
DTEND;TZID=America/Vancouver:20230223T120000
DTSTAMP:20230210T224249Z
CREATED:20230210T224249Z
LAST-MODIFIED:20230210T224249Z
UID:32798-1677110400-1677153600@scienceinvancouver.com
SUMMARY:Access to Innovation
DESCRIPTION:Our 8th Annual Access to Innovation conference is a full day event that brings together life sciences leaders from academia\, research\, health institutions\, government\, and industry to discuss emerging trends\, innovation\, economic impact\, translational science\, and policies to advance the sector. This year’s event will resume in person. \nThe BC life sciences sector has never been stronger\, leading the country in the pace of discovery and company creation. By leveraging our world-class research\, we are well-positioned to deliver innovative product solutions and services critical to the health system while driving economic diversification and competitiveness. \nAs leaders\, we need to seize the opportunity to significantly advance the sector and ensure that BC builds on the extraordinary momentum of the last few years by working together to develop policies and strategies that attract capital and talent and enable scale. The time for sustained collaborative action – between industry\, research and academia\, and government – is now. \nPlease join us as we dive into the most pressing issues facing the BC life sciences sector. \nConfirmed Speakers: \nPaul Armitage\, Partner\, Gowling WLG\nDr. Julia Bickford\, Regional Director\, Research Evaluation and Analytics\, Northern Health\nDr. Michael Chen\, Clinical Pathologist\, Department of Laboratory Medicine\, Island Health; Adjunct Assistant Professor\, University of British Columbia & University of Victoria\nAbi Coman-Walker\, COO\, Acuitas Therapeutics\nStephen Filby\, Founder & Principal Consultant\, WestPAR Consultancy\nDr. David Goodlett\, Professor\, University of Victoria; Director\, University of Victoria-Genome BC Proteomics Centre\nDr. Fraser Hof\, AVP Research\, University of Victoria\nDr. Diana Ionescu\, Clinical Professor\, University of British Columbia; Consultant Pathologist\, BC Cancer Agency\nDr. Tim Jacobs\, Director\, Molecular Design & Engineering\, AbCellera\nDr. Shirin Kalyan\, VP\, Scientific Innovation\, Qu Biologics\nDr. Barb Kinnaird\, CEO\, Response Biomedical\nDr. Véronique Lecault\, COO\, AbCellera\nJennifer Marles\, Partner\, Oyen Wiggs\nDr. Robert McMaster\, Vice Dean\, Research & Professor\, Department of Medical Genetics\, University of British Columbia\nNathan Michaels\, Director\, Precision Medicine and Genetic Services\, Ministry of Health\nAlison Orth\, Director\, Clinical Trials BC\, Michael Smith Health Research BC\nDr. Federica Di Palma\, CSO & VP\, Research and Innovation\, Genome BC\nEric Petersson\, Trade Commissioner\, Pacific Regional Office\, Global Affairs Canada\nDarcia Pope\, Chief Transformation Officer & Vice President\, Innovation & Planetary Health\, Vancouver Coastal Health\nAndrea Sambati\, President and CEO\, Boehringer Ingelheim Canada\nAngie Schick\, Executive Director\, New Ventures BC\nHelen Sheridan\, Chief Human Resources Officer\, STEMCELL Technologies\nDr. Cynthia Shippam\, Industry Technology Advisor\, National Research Council Canada – IRAP\nDr. Ted Steiner\, Professor\, Medicine & Head of the Division of Infectious Diseases\, University of British Columbia\nDr. Gavin C.E. Stuart\, Professor\, Department Obstetrics and Gynecology\, University of British Columbia\nJames Taylor\, General Manager\, Genomics Medicine\, Cytiva\nDr. Ali Tehrani\, Venture Partner\, Amplitude Ventures\nDr. Bryan Tennant\, Scientific Director\, Medical Affairs – Vaccines\, GSK\nCarlene Todd\, VP Access\, Roche\nLaura Walsh\, Senior Vice President\, Philanthropy\, VGH & UBC Hospital Foundation\nDr. Stephen Yip\, Neuropathologist\, Vancouver General Hospital; Medical Director of CGL/CCG\, BC Cancer\nConfirmed Session Themes: \nA Vision for Clinical Trials in British Columbia\nEvolving Access to Innovations in Precision Medicine\nImmuno-engineering: From Genomics to Therapeutics\nInnovations in Infection and Immunity\nLicensing and Collaboration Agreements in the Life Sciences Sector\nNavigating Government Support of IP Strategies
URL:https://scienceinvancouver.com/event/access-to-innovation-2-4/
LOCATION:Vancouver Convention Centre West\, 1055 Canada Pl\, Vancouver
ATTACH;FMTTYPE=:
END:VEVENT
END:VCALENDAR